{
  "prompt": {
    "guidelineId": "cg12027-pca-remifentanil-in-labour-guideline-pdf",
    "fieldsProcessed": [
      "humanFriendlyName",
      "organisation",
      "yearProduced",
      "summary"
    ],
    "enhancedFields": 4,
    "contentLength": 2127
  },
  "response": "{\n  \"success\": true,\n  \"enhancedFields\": [\n    {\n      \"field\": \"humanFriendlyName\",\n      \"oldValue\": null,\n      \"newValue\": \"Remifentanil PCA for Labor Pain Management\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"organisation\",\n      \"oldValue\": null,\n      \"newValue\": \"RCOG\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"yearProduced\",\n      \"oldValue\": null,\n      \"newValue\": \"I cannot find a publication year in the provided text. The guideline does not include a date or year of publication\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"summary\",\n      \"oldValue\": null,\n      \"newValue\": \"**Summary of Remifentanil PCA in Labour Guideline:** Remifentanil PCA is a safe, effective alternative for labor analgesia when epidurals are contraindicated or fail. Key safety measures include reduced bolus dose, 1:1 midwifery care, and longer lockout. **Indications:** Epidural contraindications or maternal request (if staffing allows). **Contraindications:** Inadequate staffing, opioid allergy, recent opioid use, gestation <36 weeks. **Requirements:** Patient education, continuous midwifery care, dedicated IV cannula, oxygen saturation monitoring. **Complications:** Desaturation, respiratory depression, drowsiness, CTG changes. **Monitoring:** Continuous SaO₂, CTG, sedation scoring, respiratory rate. **PCA Protocol:** - No loading dose or background infusion; max 800mcg/hour. - Anaesthetist must be present for initial bolus and first 15 minutes. - Dedicated cannula; flush after removal. - Patient-only button use; naloxone must be available. - Use during delivery/repairs; oxygen for desaturation. - Manage side effects (cyclizine for nausea, chlorpheniramine for pruritus). **Patient Education:** Explain fast-acting relief, timing with contractions, and side effects. Remifentanil is safe for neonates. **Documentation:** Complete PCA chart with settings, observations, and side-effect management. Continue monitoring for 15 minutes post-PCA\",\n      \"action\": \"added\"\n    }\n  ]\n}",
  "endpoint": "enhanceGuidelineMetadata",
  "timestamp": "2025-06-18T22-05-17",
  "textContent": "AI: DeepSeek (deepseek-chat)\n\nQ: {\n  \"guidelineId\": \"cg12027-pca-remifentanil-in-labour-guideline-pdf\",\n  \"fieldsProcessed\": [\n    \"humanFriendlyName\",\n    \"organisation\",\n    \"yearProduced\",\n    \"summary\"\n  ],\n  \"enhancedFields\": 4,\n  \"contentLength\": 2127\n}\n\nA: {\n  \"success\": true,\n  \"enhancedFields\": [\n    {\n      \"field\": \"humanFriendlyName\",\n      \"oldValue\": null,\n      \"newValue\": \"Remifentanil PCA for Labor Pain Management\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"organisation\",\n      \"oldValue\": null,\n      \"newValue\": \"RCOG\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"yearProduced\",\n      \"oldValue\": null,\n      \"newValue\": \"I cannot find a publication year in the provided text. The guideline does not include a date or year of publication\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"summary\",\n      \"oldValue\": null,\n      \"newValue\": \"**Summary of Remifentanil PCA in Labour Guideline:** Remifentanil PCA is a safe, effective alternative for labor analgesia when epidurals are contraindicated or fail. Key safety measures include reduced bolus dose, 1:1 midwifery care, and longer lockout. **Indications:** Epidural contraindications or maternal request (if staffing allows). **Contraindications:** Inadequate staffing, opioid allergy, recent opioid use, gestation <36 weeks. **Requirements:** Patient education, continuous midwifery care, dedicated IV cannula, oxygen saturation monitoring. **Complications:** Desaturation, respiratory depression, drowsiness, CTG changes. **Monitoring:** Continuous SaO₂, CTG, sedation scoring, respiratory rate. **PCA Protocol:** - No loading dose or background infusion; max 800mcg/hour. - Anaesthetist must be present for initial bolus and first 15 minutes. - Dedicated cannula; flush after removal. - Patient-only button use; naloxone must be available. - Use during delivery/repairs; oxygen for desaturation. - Manage side effects (cyclizine for nausea, chlorpheniramine for pruritus). **Patient Education:** Explain fast-acting relief, timing with contractions, and side effects. Remifentanil is safe for neonates. **Documentation:** Complete PCA chart with settings, observations, and side-effect management. Continue monitoring for 15 minutes post-PCA\",\n      \"action\": \"added\"\n    }\n  ]\n}",
  "ai_provider": "DeepSeek",
  "ai_model": "deepseek-chat",
  "token_usage": null
}